83
Participants
Start Date
November 30, 2011
Primary Completion Date
March 31, 2016
Study Completion Date
May 31, 2016
Methotrexate (Novatrex ®) + anti-H1
"Methotrexate (Novatrex ®) tablets 2.5 mg methotrexate 0.2 mg/kg/week as a single dose, orally for 8 weeks.~After 8 weeks, if the treatment is still not efficient, the dose will be increased to 0.25 mg/kg/week and continued until W18.~For anti-H1 treatment, the same molecules with the same dosage than before the recruitment will be continued, and methotrexate will be added in this group."
Placebo + anti-H1
"Placebo: 0.2 mg / kg / week as a single dose, orally for 8 weeks. After eight weeks, if the patient is still very embarrassed, the dose is increased to 0.25 mg / kg / week in a weekly dose.~For anti-H1 treatment, the same molecules with the same dosage than before the recruitment will be continued, and the placebo of methotrexate will be added in this group."
CHRU BREST Morvan, Brest
CHRU RENNES Pontchaillou, Rennes
Chru Tours, Tours
Chru Nantes, Nantes
Chru Reims, Reims
CHRU NANCY Brabois, Nancy
CHRU LILLE Huriez, Lille
Ch Le Mans, Le Mans
Hopital TENON, Paris
CHRU POITIERS La Miléterie, Poitiers
Chu Mondor, Créteil
University Hospital, Tours
OTHER